Citius Oncology Inc (CTOR)

0.99 -0.07 (-6.60%) USD  |  NASDAQ  |  Nov 18, 14:39
More

Citius Oncology EV to EBITDA

EV to EBITDA Chart

View EV to EBITDA for CTOR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical EV to EBITDA Data

View and export this data back to . Upgrade now.
Date Value

EV to EBITDA Definition

The EV to EBITDA measures the ratio between enterprise value and earnings before interest, taxes, depreciation, and amortization. This metric is important to analyze when looking at a company's true value based on how much they are valued at compared to how money they are earning.

Read full definition.

EV to EBITDA Range, Past 5 Years

--
Minimum
--
Maximum
--
Average
--
Median

EV to EBITDA Benchmarks

Citius Pharmaceuticals Inc --
Merck & Co Inc Upgrade
NovaBay Pharmaceuticals Inc --
Palatin Technologies Inc --
iBio Inc --